{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:25:40Z","timestamp":1794360340370,"version":"4.9.0"},"reference-count":18,"publisher":"Royal College of General Practitioners","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BJGP Open"],"accepted":{"date-parts":[[2025,12,22]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous work has highlighted that migraine is underdiagnosed and undertreated in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To characterise diagnosis and treatment patterns among patients with migraine in England.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design &amp; setting<\/jats:title>\n                    <jats:p>A retrospective cohort study using the Clinical Practice Research Datalink (CPRD) Aurum linked to the 2019 Index of Multiple Deprivation dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The study cohort included patients presenting to general practices with migraine at age \u226518 years from September 2012 to May 2023 (index event). Prescribed medications 12 months after index were compared across sociodemographic stratifications (age, sex, ethnic group, and deprivation). Medication overprescription was defined as \u226510 days\u2019 (opioids and triptans) or \u226515 days\u2019 (analgesics, antipyretics, and non-steroidal anti-inflammatory drugs [NSAIDs]) supply in 3 consecutive months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 1 534 807 patients with any headache or migraine were observed attending primary care in England. Of these, 876 233 (57.1%) were coded with undifferentiated or unclassified headache and 606 928 (39.5%) with a primary headache disorder. Migraine was the most coded primary headache disorder, with 476 191 adults (78.5%), constituting the final sample used for subsequent analyses. Only 36.5% of the migraine cohort were prescribed preventive medication. Regarding prescribed dose, 17.9% of those prescribed amitriptyline, 31.3% prescribed propranolol, and 31.2% prescribed topiramate reached Scottish Intercollegiate Guidelines Network (SIGN) 155 and National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries (CKS) recommended doses. In total, 62.6% of the migraine cohort were prescribed an acute medication: triptan (36.6%), and opioid (9.6%). Regarding possible medication overuse, 23.6% of triptan users and 44.3% of opioid users exhibited medication overprescription, as defined by the International Classification of Headache Disorders, 3rd edition (ICHD-3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The majority of headache presenting to primary care remains undifferentiated or unclassified. Only approximately one-third of patients diagnosed with migraine receive triptans or preventive medication. Acute medication overprescription is common and preventive medicines are poorly optimised.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3399\/bjgpo.2025.0143","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:45:11Z","timestamp":1767962711000},"page":"BJGPO.2025.0143","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and management of migraine in adults: a population-based study in England"],"prefix":"10.3399","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3996-8790","authenticated-orcid":false,"given":"David PB","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pawinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1469-6120","authenticated-orcid":false,"given":"Maciej","family":"Czachorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-5463","authenticated-orcid":false,"given":"Marzieh","family":"Araghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5989-5560","authenticated-orcid":false,"given":"Alannah M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8056-054X","authenticated-orcid":false,"given":"Lucinda","family":"Camidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-9052","authenticated-orcid":false,"given":"Elke","family":"Rottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0347-4670","authenticated-orcid":false,"given":"Hannah","family":"Gowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7907-5023","authenticated-orcid":false,"given":"Sarah","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-8109","authenticated-orcid":false,"given":"Grant","family":"O'Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026102105001006000_10.3.BJGPO.2025.0143.1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1066-0"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01795-2"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04167.x"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.4","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000078940.53438.83"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.5","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp08X264072"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.6","unstructured":"The Migraine Trust (2021) State of the migraine nation dismissed for too long: recommendations to improve migraine care in the UK, accessed. https:\/\/migrainetrust.org\/wp-content\/uploads\/2021\/09\/Dismissed-for-too-long_Recommendations-to-improve-migraine-care-in-the-UK.pdf. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.7","unstructured":"National Institute for Health and Care Excellence (NICE) (2012) Headaches in over 12s: diagnosis and management [Clinical guideline CG150]. accessed. https:\/\/www.nice.org.uk\/guidance\/cg150. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.8","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA) (2024) Release notes: CPRD Aurum June 2024. accessed. https:\/\/www.cprd.com\/sites\/default\/files\/2024-06\/2024-06%20CPRD%20Aurum%20Release%20Notes.pdf. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.9","unstructured":"MHRA (2022) CPRD: Small area level data based on practice postcode: documentation and data dictionary. accessed. https:\/\/cprd.com\/sites\/default\/files\/2022-05\/Documentation_SmallAreaData_Practice_set22_v3.4_1.pdf. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.10","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.11","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) (2023) SIGN 155: Pharmacological management of migraine. accessed. https:\/\/www.sign.ac.uk\/media\/2077\/sign-155-migraine-2023-update-v3.pdf. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.12","unstructured":"NICE (2025) Scenario: Migraine in adults. accessed. https:\/\/cks.nice.org.uk\/topics\/migraine\/management\/adults. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.13","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-023-02242-y"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.14","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.15","unstructured":"NHS Business Services Authority (NHSBSA) (2022) Dependency forming medicines: England 2015\/16 to 2021\/22. accessed. https:\/\/nhsbsa-opendata.s3.eu-west-2.amazonaws.com\/dfm\/dfm_annual_2021_22_v001.html. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.16","unstructured":"Public Health England (2019) Dependence on prescription: medicines linked to deprivation. accessed. https:\/\/www.gov.uk\/government\/news\/dependence-on-prescription-medicines-linked-to-deprivation. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.17","unstructured":"NICE (2025) Drugs for acute migraine, accessed. https:\/\/cks.nice.org.uk\/topics\/migraine\/prescribing-information\/drugs-for-acute-migraine. 13 May 2026."},{"key":"2026102105001006000_10.3.BJGPO.2025.0143.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003270"}],"container-title":["BJGP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGPO.2025.0143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:37:59Z","timestamp":1792607879000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgpopen.org\/lookup\/doi\/10.3399\/BJGPO.2025.0143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,10,21]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.3399\/BJGPO.2025.0143"],"URL":"https:\/\/doi.org\/10.3399\/bjgpo.2025.0143","relation":{},"ISSN":["2398-3795"],"issn-type":[{"value":"2398-3795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}